Angioscopic Comparison of Early- and Mid-Term Vascular Responses Following Treatment of ST-Elevation Acute Myocardial Infarction With Biodegradable vs. Durable Polymer Everolimus-Eluting Stents　― A Prespecified Subanalysis of the MECHANISM AMI RCT ―-Reference-Cited by-同舟云学术

Angioscopic Comparison of Early- and Mid-Term Vascular Responses Following Treatment of ST-Elevation Acute Myocardial Infarction With Biodegradable vs. Durable Polymer Everolimus-Eluting Stents　― A Prespecified Subanalysis of the MECHANISM AMI RCT ―

Published:2023-04-25 Issue:5 Volume:87 Page:619-628
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nakatani Shimpei¹,Sotomi Yohei¹,Suzuki Satoshi¹,Kobayashi Tomoaki¹,Hamanaka Yuma¹,Omatsu Takashi¹,Ishida Masaru²,Kakizaki Shunsuke³,Otake Hiromasa³,Morino Yoshihiro²,Higuchi Yoshiharu¹,

Affiliation:

1. Department of Cardiology, Osaka Police Hospital

2. Division of Cardiology, Department of Internal Medicine, Iwate Medical University

3. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/5/87_CJ-22-0534/_pdf

Reference30 articles.

1. 1. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients. JACC Cardiovasc Interv 2013; 6: 1267–1274, doi:10.1016/j.jcin.2013.06.015.

2. 2. Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet 2012; 380: 1482–1490, doi:10.1016/S0140-6736(12)61223-9.

3. 3. Morino Y, Terashita D, Otake H, Kikuchi T, Fusazaki T, Kuriyama N, et al. Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of ST-elevation myocardial infarction: Results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study). Cardiovasc Interv Ther 2019; 34: 14–24, doi:10.1007/s12928-017-0507-4.

4. 4. Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation 2011; 123: 1400–1409, doi:10.1161/CIRCULATIONAHA.110.003210.

5. 5. Yokoyama S, Takano M, Yamamoto M, Inami S, Sakai S, Okamatsu K, et al. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: From healing response to atherosclerotic transformation of neointima. Circ Cardiovasc Interv 2009; 2: 205–212, doi:10.1161/CIRCINTERVENTIONS.109.854679.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17

2. The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction;Journal of Atherosclerosis and Thrombosis;2024-02-01